Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marie Garraud"'
Autor:
Bruno Palmier, Dominique Lerouet, Benoît Barsacq, Charlotte Abbou, Bérard Coqueran, Isabelle Margaill, Catherine Marchand-Leroux, Virginie Beray-Berthat, Mohamad El Amki, Fei Teng, Marie Garraud
Publikováno v:
Molecular neurobiology. 55(12)
Benefits from thrombolysis with recombinant tissue plasminogen activator (rt-PA) after ischemic stroke remain limited due to a narrow therapeutic window, low reperfusion rates, and increased risk of hemorrhagic transformations (HT). Experimental data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4789f8a4190e7334e692b3d90170d04
https://pubmed.ncbi.nlm.nih.gov/29651748
https://pubmed.ncbi.nlm.nih.gov/29651748
Autor:
Jean-Marie Renard, Kahina Khacef, Anne-Clémence Vion, Marie Garraud, Claire Leconte, Catherine Marchand-Leroux, Isabelle Margaill, Virginie Beray-Berthat, Chantal M. Boulanger, Min Yin
Publikováno v:
Journal of the Neurological Sciences
Journal of the Neurological Sciences, Elsevier, 2016, 370, pp.187-195. ⟨10.1016/j.jns.2016.09.026⟩
Journal of the Neurological Sciences, Elsevier, 2016, 370, pp.187-195. ⟨10.1016/j.jns.2016.09.026⟩
Thrombolysis with recombinant tissue plasminogen activator (rt-PA) is currently the only approved pharmacological strategy for acute ischemic stroke. However, rt-PA exhibits vascular toxicity mainly due to endothelial damage. To investigate the mecha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5d3c0be9d0aca54384b4e9b44a7b98d
https://pubmed.ncbi.nlm.nih.gov/27772757
https://pubmed.ncbi.nlm.nih.gov/27772757
Autor:
Frédéric Szeremeta, Niamh Slane, Marie Garraud, Isabelle Margaill, Bérard Coqueran, Catherine Marchand-Leroux, Michel Plotkine, Mélanie Kuntz, Clémentine Lesbats, Vincent Berezowski, Virginie Beray-Berthat, Daniel Scherman, Fei Teng, Cyrielle Bedfert, Bich-Thuy Doan, Bruno Palmier, Johan Hachani
Publikováno v:
Experimental Neurology
Experimental Neurology, Elsevier, 2013, 248, pp.416-428. ⟨10.1016/j.expneurol.2013.07.007⟩
Experimental Neurology, Elsevier, 2013, 248, pp.416-428. ⟨10.1016/j.expneurol.2013.07.007⟩
International audience; Recombinant tissue plasminogen activator (rt-PA) is the only pharmacological treatment approved for thrombolysis in patients suffering from ischemic stroke, but its administration aggravates the risk of hemorrhagic transformat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4006c252fefd62ef67f5ddd473531dd5
https://hal.archives-ouvertes.fr/hal-02070926
https://hal.archives-ouvertes.fr/hal-02070926
